Eton Pharmaceuticals (ETON) EPS (Diluted) Growth (1y) (2021 - 2026)
Eton Pharmaceuticals (ETON) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.76 Bn | 1.73 Bn | 25.41 Mn | 467.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 467.38% |
| Dec 31, 2025 | 100.28% |
| Sep 30, 2025 | -100.30% |
| Jun 30, 2025 | 17.47% |
| Mar 31, 2025 | -88.09% |
| Dec 31, 2024 | -30,977.41% |
| Sep 30, 2024 | 105,000.73% |
| Jun 30, 2024 | -67,333.68% |
| Mar 31, 2024 | 69.79% |
| Dec 31, 2023 | -165.51% |
| Sep 30, 2023 | 81.25% |
| Jun 30, 2023 | 100.28% |
| Mar 31, 2023 | -49,368.23% |
| Dec 31, 2022 | 169.12% |
| Sep 30, 2022 | 50.21% |
| Jun 30, 2022 | -77,444.04% |
| Mar 31, 2022 | -209.31% |
| Dec 31, 2021 | 111.23% |
| Sep 30, 2021 | 22.14% |
| Jun 30, 2021 | 64.49% |